Pharmaceutical Business review

Surrey Clinical Research Centre signs five year agreement for OmniComm Systems’ Promasys

After a thorough evaluation process of various commercially available technologies, Surrey CRC selected Promasys technology to manage its clinical research activities. Promasys ranked highest across all categories including ease of use, fast study build, data quality and integrity and volunteer recruitment.

Promasys’ versatility through its mobile technology and overall functionality, as well as its lower total cost-of-ownership, was also a significant factor in the decision.

Surrey CRC data management head Carol Stillwell noted the company looks forward to working with OmniComm Promasys.

"Having worked with several commercial technologies over the past couple of years, we were impressed by the ease of operation of the Promasys system, and with the backing of an established company such as OmniComm feel that Promasys will go from strength to strength," Stillwell.

Promasys will be used by Surrey CRC to support both in-house and external studies including investigator initiated trials (IITs), National Health Service (NHS) studies, and industry sponsored trials.